Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs: ECG-ViEW

M. Y. Park; D. Yoon; N. K. Choi; J. Lee; K. Lee; H. S. Lim; B. J. Park; J. H. Kim; R. W. Park

doi:10.1038/clpt.2012.93

Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs: ECG-ViEW

M. Y. Park, D. Yoon, N. K. Choi, J. Lee, K. Lee, H. S. Lim, B. J. Park, J. H. Kim, R. W. Park

Department of Health Convergence

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Information about the QT interval from surface electrocardiograms (ECGs) is essential for surveillance of the proarrhythmia potential of marketed drugs. However, ECG records obtained in daily practice cannot be easily used for this purpose without labor-intensive manual effort. This study was aimed at constructing an open-access QT database, the Electrocardiogram Vigilance with Electronic Data Warehouse (ECG-ViEW). This longitudinal observational database contains 710,369 measurements of QT and associated clinical data from 371,401 patients. The de-identified database is freely available at http://www.ecgview. org.

Original language	English
Pages (from-to)	393-396
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	92
Issue number	3
DOIs	https://doi.org/10.1038/clpt.2012.93
State	Published - Sep 2012

Access to Document

10.1038/clpt.2012.93

Cite this

@article{c6d236a7f53a4008bc2d3a34a336451b,

title = "Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs: ECG-ViEW",

abstract = "Information about the QT interval from surface electrocardiograms (ECGs) is essential for surveillance of the proarrhythmia potential of marketed drugs. However, ECG records obtained in daily practice cannot be easily used for this purpose without labor-intensive manual effort. This study was aimed at constructing an open-access QT database, the Electrocardiogram Vigilance with Electronic Data Warehouse (ECG-ViEW). This longitudinal observational database contains 710,369 measurements of QT and associated clinical data from 371,401 patients. The de-identified database is freely available at http://www.ecgview. org.",

author = "Park, {M. Y.} and D. Yoon and Choi, {N. K.} and J. Lee and K. Lee and Lim, {H. S.} and Park, {B. J.} and Kim, {J. H.} and Park, {R. W.}",

year = "2012",

month = sep,

doi = "10.1038/clpt.2012.93",

language = "English",

volume = "92",

pages = "393--396",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs

T2 - ECG-ViEW

AU - Park, M. Y.

AU - Yoon, D.

AU - Choi, N. K.

AU - Lee, J.

AU - Lee, K.

AU - Lim, H. S.

AU - Park, B. J.

AU - Kim, J. H.

AU - Park, R. W.

PY - 2012/9

Y1 - 2012/9

N2 - Information about the QT interval from surface electrocardiograms (ECGs) is essential for surveillance of the proarrhythmia potential of marketed drugs. However, ECG records obtained in daily practice cannot be easily used for this purpose without labor-intensive manual effort. This study was aimed at constructing an open-access QT database, the Electrocardiogram Vigilance with Electronic Data Warehouse (ECG-ViEW). This longitudinal observational database contains 710,369 measurements of QT and associated clinical data from 371,401 patients. The de-identified database is freely available at http://www.ecgview. org.

AB - Information about the QT interval from surface electrocardiograms (ECGs) is essential for surveillance of the proarrhythmia potential of marketed drugs. However, ECG records obtained in daily practice cannot be easily used for this purpose without labor-intensive manual effort. This study was aimed at constructing an open-access QT database, the Electrocardiogram Vigilance with Electronic Data Warehouse (ECG-ViEW). This longitudinal observational database contains 710,369 measurements of QT and associated clinical data from 371,401 patients. The de-identified database is freely available at http://www.ecgview. org.

UR - http://www.scopus.com/inward/record.url?scp=84865418905&partnerID=8YFLogxK

U2 - 10.1038/clpt.2012.93

DO - 10.1038/clpt.2012.93

M3 - Article

C2 - 22828716

AN - SCOPUS:84865418905

SN - 0009-9236

VL - 92

SP - 393

EP - 396

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 3

ER -

Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs: ECG-ViEW

Abstract

Access to Document

Fingerprint

Cite this